Search Results
Feb 24, 2026, 01:26 ET BlueNord Announces Fourth Quarter 2025 Results and Proposed Cash Dividend for the Quarter
representing the highest quarterly production in the Company's history. The performance reflects continued ramp-up at the Tyra hub alongside stable contribution from the base assets. At Tyra, a planned shutdown in October was successfully completed, improving efficiency and reducing unplanned shutdowns.
More news about: BlueNord ASA
Feb 23, 2026, 17:30 ET Tyra Biosciences Announces Poster Presentations at the 2026 ASCO® Genitourinary (GU) Cancers Symposium
https://ir.tyra.bio.About Tyra BiosciencesTyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large
More news about: Tyra Biosciences
Feb 19, 2026, 16:05 ET Tyra Biosciences to Participate in Upcoming Investor Conferences
website and will be available for replay following the event.About Tyra BiosciencesTyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large
More news about: Tyra Biosciences
Feb 06, 2026, 01:37 ET BlueNord: Preliminary Production for January 2026
was 43.1 mboepd net to the Company. The Tyra hub delivered an average production of 22.4 mboepd net to BlueNord. On 25 January, a gas production rate of 227 mmscfpd was achieved, representing the highest daily gas export since the restart of the Tyra hub. Production during January was impacted by
More news about: BlueNord ASA
Jan 07, 2026, 01:22 ET BlueNord: Preliminary Production for December 2025
preliminary production was 47.4 mboepd net to the Company. During the month, the Tyra hub delivered an average of 25.1 mboepd net to BlueNord, marking the highest monthly production since the restart of the Tyra facilities. Production remained stable throughout the month, with a peak rate of c.27
More news about: BlueNord ASA
Jan 02, 2026, 09:00 ET APUS Celebrates Top Scholars for Outstanding Academic Achievement
Jr Felicia Bennett Joshua Bennett Katie Bennett Charles Benton Chaz Benton Tiffany Benton Tyra Bergan Marc Bergeron Elizabeth Bernard Jamie Berndt Autumn Berry Giany Berry Jonathan Berta Madeline
More news about: American Public University System
Dec 15, 2025, 17:45 ET Cirque du Soleil and Grupo Vidanta Presented the Highly-Anticipated World Premiere of LUDÕ, a Submersive Aquatic Spectacle in Mexico
The special night brought out celebrities including Rebel Wilson, Tyra Banks, Paula Abdul, Niecy Nash, Mario Lopez, Sunny Hostin, Teresa Giudice, and many more. The premiere welcomed close to 700 guests, who
More news about: Grupo Vidanta
Dec 15, 2025, 13:00 ET Cirque du Soleil y Grupo Vidanta presentan el tan esperado estreno mundial de LUDÕ, un espectáculo acuático submersivo en México
La velada reunió a celebridades nacionales e internacionales entre las que destacaron Rebel Wilson, Tyra Banks, Paula Abdul, Niecy Nash, Mario Lopez, Sunny Hostin, Teresa Giudice, Jacky Bracamontes, Carlos Ponce, Andy Benavides, Geraldine Bazan,
More news about: Grupo Vidanta
Dec 10, 2025, 10:56 ET Children's Hospital of Philadelphia Receives $1.7 Million Investment from UnitedHealthcare to Support Essential Community Programs
Tyra Bryant-Stephens, MD, Medical Director of the Community Asthma Prevention Program and Chief Health Equity Officer of the Center for Health Equity
More news about: Children's Hospital of Philadelphia
Dec 08, 2025, 01:15 ET BlueNord: Preliminary Production for November 2025
production figures for November 2025. In November 2025, the preliminary production was 43.3 mboepd net to the Company. During the month, the Tyra hub delivered an average production of 20.6 mboepd. In the beginning of November, production was ramping up after the planned full-field shutdown in
More news about: BlueNord ASA
Dec 01, 2025, 08:00 ET Tyra Biosciences Strengthens Leadership Team with Appointments of Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer
Patients page of our website for more information on our clinical trials.About Tyra BiosciencesTyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large
More news about: Tyra Biosciences
Nov 12, 2025, 16:05 ET Tyra Biosciences Announces Participation at Upcoming Investor Events
will be available for replay following the event. About Tyra Biosciences Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that
More news about: Tyra Biosciences
Nov 05, 2025, 16:05 ET Tyra Biosciences Reports Third Quarter 2025 Financial Results and Highlights
mUC. TYRA is also developing TYRA-430, an oral, investigational FGFR4/3-biased inhibitor for FGF19+/FGFR4-driven cancers, in the SURF431 study for advanced HCC, and TYRA-200, an oral, investigational, FGFR1/2/3 inhibitor, in the SURF201 study for metastatic intrahepatic cholangiocarcinoma. TYRA is based
More news about: Tyra Biosciences
Nov 05, 2025, 09:00 ET Akeneo Empowers Businesses to Deliver Better Product Experiences Through Smarter, AI-Driven Product Data Flow
"The Autumn release marks a pivotal moment in the evolution of our Product Cloud that focuses on the connectivity layer," said Andy Tyra, Chief Product Officer at Akeneo. "By extending the power of AI to connect people, processes, and technology, we are equipping our customers with the
More news about: Akeneo
Oct 29, 2025, 01:43 ET BlueNord Announces Third Quarter 2025: Robust Results & Proposed Cash Dividend for the Quarter
Gorm and Halfdan produced 20.2 mboepd during the quarter. Tyra continued its ramp up, averaging 18.9 mboepd during the quarter and reaching its highest average monthly production since restart at 22.0 mboepd in September. As production from the Tyra hub continues to increase, it is making a significant contribution
More news about: BlueNord ASA
Oct 06, 2025, 01:38 ET BlueNord: Preliminary Production for September 2025
BlueNord. The Tyra hub produced 22.0 mboepd net, which is the highest monthly production since the restart of the Tyra facilities. Production stability improved significantly compared to previous months. Efforts to further enhance reliability and performance at Tyra are ongoing, with actions
More news about: BlueNord ASA